1. Home
  2. ALT vs HLLY Comparison

ALT vs HLLY Comparison

Compare ALT & HLLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALT
  • HLLY
  • Stock Information
  • Founded
  • ALT 1997
  • HLLY 1903
  • Country
  • ALT United States
  • HLLY United States
  • Employees
  • ALT N/A
  • HLLY N/A
  • Industry
  • ALT Biotechnology: Pharmaceutical Preparations
  • HLLY Auto Parts:O.E.M.
  • Sector
  • ALT Health Care
  • HLLY Consumer Discretionary
  • Exchange
  • ALT Nasdaq
  • HLLY Nasdaq
  • Market Cap
  • ALT 397.4M
  • HLLY 353.7M
  • IPO Year
  • ALT N/A
  • HLLY N/A
  • Fundamental
  • Price
  • ALT $4.19
  • HLLY $2.14
  • Analyst Decision
  • ALT Strong Buy
  • HLLY Strong Buy
  • Analyst Count
  • ALT 6
  • HLLY 6
  • Target Price
  • ALT $18.20
  • HLLY $5.21
  • AVG Volume (30 Days)
  • ALT 11.7M
  • HLLY 529.6K
  • Earning Date
  • ALT 08-07-2025
  • HLLY 08-06-2025
  • Dividend Yield
  • ALT N/A
  • HLLY N/A
  • EPS Growth
  • ALT N/A
  • HLLY N/A
  • EPS
  • ALT N/A
  • HLLY N/A
  • Revenue
  • ALT $20,000.00
  • HLLY $596,632,000.00
  • Revenue This Year
  • ALT N/A
  • HLLY $0.08
  • Revenue Next Year
  • ALT $1,557,547.90
  • HLLY $4.60
  • P/E Ratio
  • ALT N/A
  • HLLY N/A
  • Revenue Growth
  • ALT N/A
  • HLLY N/A
  • 52 Week Low
  • ALT $2.90
  • HLLY $1.60
  • 52 Week High
  • ALT $11.16
  • HLLY $4.08
  • Technical
  • Relative Strength Index (RSI)
  • ALT 39.67
  • HLLY 50.82
  • Support Level
  • ALT $4.33
  • HLLY $2.16
  • Resistance Level
  • ALT $4.79
  • HLLY $2.32
  • Average True Range (ATR)
  • ALT 0.52
  • HLLY 0.09
  • MACD
  • ALT -0.16
  • HLLY 0.02
  • Stochastic Oscillator
  • ALT 26.92
  • HLLY 55.00

About ALT Altimmune Inc.

Altimmune Inc is a clinical-stage biopharmaceutical company focused on developing treatments for obesity, metabolic diseases, and liver diseases. Its product candidate, pemvidutide (formerly known as ALT-801), is a novel, investigational, peptide-based GLP-1/glucagon dual receptor agonist. Pemvidutide is currently in clinical development for obesity and metabolic-associated steatohepatitis (MASH). The company also plans to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.

About HLLY Holley Inc.

Holley Inc is a designer, marketer, and manufacturer of high-performance automotive aftermarket products, featuring a portfolio of iconic brands serving the car and truck industry. It offers a diversified line of performance automotive products including fuel injection systems, tuners, exhaust products, carburetors, safety equipment and various other performance automotive products. The Company's products are designed to enhance street, off-road, recreational and competitive vehicle performance through increased horsepower, torque and drivability. The company's brands include Holley, APR, MSD and Flowmaster, among others. It derives revenue from the U.S. and Italy, of which prime revenue is derived from the U.S.

Share on Social Networks: